Item request has been placed!
×
Item request cannot be made.
×

Processing Request
RELENTLESS PERSISTENCE TO COMMERCIALISE: Cyban Pty Ltd is an Australian medical technology company positioning itself to become the emerging leader in non-invasive critical organ pulse oximetry.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- المؤلفون: FAFIANI, BRENDAN
- المصدر:
Australasian Biotechnology. Sep2022, Vol. 32 Issue 2, p65-67. 3p.
- الموضوع:
- معلومة اضافية
- نبذة مختصرة :
The article reports that Cyban Pty Ltd. is an Australian medical technology company positioning itself to become the emerging leader in non-invasive critical organ pulse oximetry, persistence to commercialise. Topics include Cyban's innovation in pulse oximetry solves the fundamental challenge of removing skin contamination from the reflected signal; and brain hypoxia treatments to maintain adequate brain oxygen levels and prevent secondary brain injury are often straightforward and effective.
No Comments.